United States Ophthalmology Drugs Market Report 2016

November 2016 | 121 pages | ID: U09246D4A9DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ophthalmology Drugs

Revenue, means the sales value of Ophthalmology Drugs

This report studies sales (consumption) of Ophthalmology Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer Inc
• Hoya Corporation
• Bayer
• Novartis International AG
• Abbott Medical Optics, Inc.
• Ziemer Ophthalmic Systems AG
• Regeneron
• Johnson & Johnson Vision Care, Inc.
• Bausch & Lomb Inc.
• Topcon Corporation
• Ellex Medical Lasers Ltd.
• Alcon Inc.
• Merck & Co., Inc
• Spark Therapeutics
• Insight Vision Inc.
• Roche Holding Ltd
• Ophthotech
• Novagali Pharma S A
• Allergan, Inc.
• Carl-Zeiss AG
• Santen
• Essilor International S.A.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Ophthalmology Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Ophthalmology Drugs Market Report 2016

1 OPHTHALMOLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmology Drugs
1.2 Classification of Ophthalmology Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Ophthalmology Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ophthalmology Drugs (2011-2021)
  1.4.1 United States Ophthalmology Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Ophthalmology Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES OPHTHALMOLOGY DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Ophthalmology Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ophthalmology Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ophthalmology Drugs Average Price by Manufactures (2015 and 2016)
2.4 Ophthalmology Drugs Market Competitive Situation and Trends
  2.4.1 Ophthalmology Drugs Market Concentration Rate
  2.4.2 Ophthalmology Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OPHTHALMOLOGY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Ophthalmology Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Ophthalmology Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Ophthalmology Drugs Price by Type (2011-2016)
3.4 United States Ophthalmology Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES OPHTHALMOLOGY DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Ophthalmology Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Ophthalmology Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES OPHTHALMOLOGY DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer Inc
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Ophthalmology Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Inc Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Hoya Corporation
  5.2.2 Ophthalmology Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Hoya Corporation Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer
  5.3.2 Ophthalmology Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Novartis International AG
  5.4.2 Ophthalmology Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Novartis International AG Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Abbott Medical Optics, Inc.
  5.5.2 Ophthalmology Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Abbott Medical Optics, Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Ziemer Ophthalmic Systems AG
  5.6.2 Ophthalmology Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Ziemer Ophthalmic Systems AG Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Regeneron
  5.7.2 Ophthalmology Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Regeneron Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Johnson & Johnson Vision Care, Inc.
  5.8.2 Ophthalmology Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Johnson & Johnson Vision Care, Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Bausch & Lomb Inc.
  5.9.2 Ophthalmology Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Bausch & Lomb Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Topcon Corporation
  5.10.2 Ophthalmology Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Topcon Corporation Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Ellex Medical Lasers Ltd.
5.12 Alcon Inc.
5.13 Merck & Co., Inc
5.14 Spark Therapeutics
5.15 Insight Vision Inc.
5.16 Roche Holding Ltd
5.17 Ophthotech
5.18 Novagali Pharma S A
5.19 Allergan, Inc.
5.20 Carl-Zeiss AG
5.21 Santen
5.22 Essilor International S.A.

6 OPHTHALMOLOGY DRUGS MANUFACTURING COST ANALYSIS

6.1 Ophthalmology Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Ophthalmology Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Ophthalmology Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Ophthalmology Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES OPHTHALMOLOGY DRUGS MARKET FORECAST (2016-2021)

10.1 United States Ophthalmology Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Ophthalmology Drugs Sales Forecast by Type (2016-2021)
10.3 United States Ophthalmology Drugs Sales Forecast by Application (2016-2021)
10.4 Ophthalmology Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmology Drugs
Table Classification of Ophthalmology Drugs
Figure United States Sales Market Share of Ophthalmology Drugs by Type in 2015
Table Application of Ophthalmology Drugs
Figure United States Sales Market Share of Ophthalmology Drugs by Application in 2015
Figure United States Ophthalmology Drugs Sales and Growth Rate (2011-2021)
Figure United States Ophthalmology Drugs Revenue and Growth Rate (2011-2021)
Table United States Ophthalmology Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Ophthalmology Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ophthalmology Drugs Sales Share by Manufacturers
Figure 2016 Ophthalmology Drugs Sales Share by Manufacturers
Table United States Ophthalmology Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Ophthalmology Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ophthalmology Drugs Revenue Share by Manufacturers
Table 2016 United States Ophthalmology Drugs Revenue Share by Manufacturers
Table United States Market Ophthalmology Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ophthalmology Drugs Average Price of Key Manufacturers in 2015
Figure Ophthalmology Drugs Market Share of Top 3 Manufacturers
Figure Ophthalmology Drugs Market Share of Top 5 Manufacturers
Table United States Ophthalmology Drugs Sales by Type (2011-2016)
Table United States Ophthalmology Drugs Sales Share by Type (2011-2016)
Figure United States Ophthalmology Drugs Sales Market Share by Type in 2015
Table United States Ophthalmology Drugs Revenue and Market Share by Type (2011-2016)
Table United States Ophthalmology Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ophthalmology Drugs by Type (2011-2016)
Table United States Ophthalmology Drugs Price by Type (2011-2016)
Figure United States Ophthalmology Drugs Sales Growth Rate by Type (2011-2016)
Table United States Ophthalmology Drugs Sales by Application (2011-2016)
Table United States Ophthalmology Drugs Sales Market Share by Application (2011-2016)
Figure United States Ophthalmology Drugs Sales Market Share by Application in 2015
Table United States Ophthalmology Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Ophthalmology Drugs Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc Ophthalmology Drugs Sales Market Share (2011-2016)
Table Hoya Corporation Basic Information List
Table Hoya Corporation Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hoya Corporation Ophthalmology Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ophthalmology Drugs Sales Market Share (2011-2016)
Table Novartis International AG Basic Information List
Table Novartis International AG Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis International AG Ophthalmology Drugs Sales Market Share (2011-2016)
Table Abbott Medical Optics, Inc. Basic Information List
Table Abbott Medical Optics, Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Medical Optics, Inc. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Ziemer Ophthalmic Systems AG Basic Information List
Table Ziemer Ophthalmic Systems AG Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ziemer Ophthalmic Systems AG Ophthalmology Drugs Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Ophthalmology Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Vision Care, Inc. Basic Information List
Table Johnson & Johnson Vision Care, Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Vision Care, Inc. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Bausch & Lomb Inc. Basic Information List
Table Bausch & Lomb Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bausch & Lomb Inc. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Topcon Corporation Basic Information List
Table Topcon Corporation Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Topcon Corporation Ophthalmology Drugs Sales Market Share (2011-2016)
Table Ellex Medical Lasers Ltd. Basic Information List
Table Ellex Medical Lasers Ltd. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ellex Medical Lasers Ltd. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Alcon Inc. Basic Information List
Table Alcon Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alcon Inc. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Merck & Co., Inc Basic Information List
Table Merck & Co., Inc Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co., Inc Ophthalmology Drugs Sales Market Share (2011-2016)
Table Spark Therapeutics Basic Information List
Table Spark Therapeutics Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spark Therapeutics Ophthalmology Drugs Sales Market Share (2011-2016)
Table Insight Vision Inc. Basic Information List
Table Insight Vision Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Insight Vision Inc. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Roche Holding Ltd Basic Information List
Table Roche Holding Ltd Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Holding Ltd Ophthalmology Drugs Sales Market Share (2011-2016)
Table Ophthotech Basic Information List
Table Ophthotech Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ophthotech Ophthalmology Drugs Sales Market Share (2011-2016)
Table Novagali Pharma S A Basic Information List
Table Novagali Pharma S A Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novagali Pharma S A Ophthalmology Drugs Sales Market Share (2011-2016)
Table Allergan, Inc. Basic Information List
Table Allergan, Inc. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan, Inc. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Carl-Zeiss AG Basic Information List
Table Carl-Zeiss AG Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Carl-Zeiss AG Ophthalmology Drugs Sales Market Share (2011-2016)
Table Santen Basic Information List
Table Santen Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santen Ophthalmology Drugs Sales Market Share (2011-2016)
Table Essilor International S.A. Basic Information List
Table Essilor International S.A. Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Essilor International S.A. Ophthalmology Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmology Drugs
Figure Manufacturing Process Analysis of Ophthalmology Drugs
Figure Ophthalmology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmology Drugs Major Manufacturers in 2015
Table Major Buyers of Ophthalmology Drugs
Table Distributors/Traders List
Figure United States Ophthalmology Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Ophthalmology Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Ophthalmology Drugs Production Forecast by Type (2016-2021)
Table United States Ophthalmology Drugs Consumption Forecast by Application (2016-2021)